Smith & Nephew plc (SNN)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous Close | 24.44 |
| Open | 25.09 |
| Bid | 21.59 x 800 |
| Ask | 24.84 x 800 |
| Day's Range | 24.72 - 25.16 |
| 52 Week Range | 21.53 - 32.71 |
| Volume | |
| Avg. Volume | 959,937 |
| Market Cap | 10.833B |
| Beta (5Y Monthly) | 0.51 |
| PE Ratio (TTM) | 41.30 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.75 (3.03%) |
| Ex-Dividend Date | Apr 01, 2024 |
| 1y Target Est | N/A |
- The Guardian
Nearly half of Smith & Nephew investors revolt against CEO pay rise
Medical device manufacturer’s policy ultimately passed, making maximum payout for Deepak Nath $11.8m
- Simply Wall St.
With 83% ownership of the shares, Smith & Nephew plc (LON:SN.) is heavily dominated by institutional owners
Key Insights Given the large stake in the stock by institutions, Smith & Nephew's stock price might be vulnerable to...
- Insider Monkey
Here’s Why You Should Invest in Smith & Nephew plc (SNN)
Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. For the quarter ended March 31, 2024, the fund returned 0.11% compared to the MSCI World ex U.S. Index benchmark’s 5.59% return. Since its inception in September 1992, the fund returned an […]
© 2024 Yahoo. All rights reserved.